QURE vs XLU
Uniqure NV (QURE) versus XLU (XLU) — a side-by-side from cached financials, not a winner call.
Uniqure NV (QURE) is a biotechnology company listed on NASDAQ.
XLU (XLU) common stock.
Latest reported QURE revenue for 2025-12-31 was $16.1M. Net income was -$199.0M. Revenue was down 40.6% from 2024-12-31 to 2025-12-31. QURE currently screens at market cap $3.04B.
XLU does not have a complete income-statement cache yet.
QURE currently screens at market cap $3.04B. XLU currently screens at market cap $0.
Not investment advice. Open the QURE and XLU stock pages for the full models.
Not investment advice.